KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingShares Repurchased
Ratios

Fulgent Genetics (FLGT) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $54.2 million.

  • Fulgent Genetics' Accumulated Depreciation & Amortization rose 1035.57% to $54.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.2 million, marking a year-over-year increase of 1035.57%. This contributed to the annual value of $51.7 million for FY2024, which is 15.11% up from last year.
  • As of Q3 2025, Fulgent Genetics' Accumulated Depreciation & Amortization stood at $54.2 million, which was up 1035.57% from $58.7 million recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Accumulated Depreciation & Amortization ranged from a high of $58.7 million in Q2 2025 and a low of $12.8 million during Q1 2021
  • In the last 5 years, Fulgent Genetics' Accumulated Depreciation & Amortization had a median value of $46.1 million in 2023 and averaged $39.6 million.
  • Per our database at Business Quant, Fulgent Genetics' Accumulated Depreciation & Amortization skyrocketed by 12048.4% in 2022 and then crashed by 851.49% in 2024.
  • Quarter analysis of 5 years shows Fulgent Genetics' Accumulated Depreciation & Amortization stood at $19.6 million in 2021, then soared by 120.48% to $43.3 million in 2022, then rose by 19.3% to $51.6 million in 2023, then grew by 0.15% to $51.7 million in 2024, then rose by 4.81% to $54.2 million in 2025.
  • Its last three reported values are $54.2 million in Q3 2025, $58.7 million for Q2 2025, and $54.9 million during Q1 2025.